Altimmune, Inc. (ALT)
NASDAQ: ALT · Real-Time Price · USD
3.880
+0.340 (9.60%)
At close: Mar 9, 2026, 4:00 PM EDT
3.820
-0.060 (-1.55%)
After-hours: Mar 9, 2026, 7:59 PM EDT

Altimmune Revenue

In the year 2025, Altimmune had annual revenue of $41.00K with 105.00% growth. Altimmune had revenue of $26.00K in the quarter ending December 31, 2025, with 420.00% growth.

Revenue (ttm)
$41.00K
Revenue Growth
+105.00%
P/S Ratio
12,309.06
Revenue / Employee
$695
Employees
59
Market Cap
504.67M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202541.00K21.00K105.00%
Dec 31, 202420.00K-406.00K-95.31%
Dec 31, 2023426.00K494.00K-
Dec 31, 2022-68.00K-4.48M-
Dec 31, 20214.41M-3.78M-46.12%
Dec 31, 20208.19M2.38M41.09%
Dec 31, 20195.80M-4.53M-43.85%
Dec 31, 201810.33M-407.15K-3.79%
Dec 31, 201710.74M7.50M231.82%
Dec 31, 20163.24M-7.40M-69.59%
Dec 31, 201510.64M450.46K4.42%
Dec 31, 201410.19M-7.72M-43.11%
Dec 31, 201317.91M-7.26M-28.85%
Dec 31, 201225.18M909.61K3.75%
Dec 31, 201124.27M3.27M15.59%
Dec 31, 201020.99M-6.56M-23.80%
Dec 31, 200927.55M-5.36M-16.29%
Dec 31, 200832.91M18.27M124.75%
Dec 31, 200714.64M12.98M780.39%
Dec 31, 20061.66M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition